Watchlist Manager

Watchlist

Price: 32.05 TWD 0.16% Market Closed

Market Cap: NT$6.4B

	Taiyen Biotech Co Ltd TWSE:1737	TW
	Shimao Group Holdings Ltd HKEX:813	HK
	Sriwahana Adityakarta Tbk PT IDX:SWAT	ID
M	Magnit PAO LSE:MGNT	RU
B	Biolog Device Co Ltd KOSDAQ:208710	KR
	Brightsphere Investment Group Inc NYSE:BSIG	US
	Nutrien Ltd TSX:NTR	CA
	AAK AB (publ) STO:AAK	SE
H	Hasti Finance Ltd BSE:531387	IN
P	PT Nusantara Sawit Sejahtera Tbk IDX:NSSS	ID
D	Doosan Tesna Inc KOSDAQ:131970	KR
	Gujarat State Petronet Ltd NSE:GSPL	IN
B	Bioretec Oy OMXH:BRETEC	FI

Cash Flow Statement

Currency: TWD

	Dec-2004	Mar-2005	Jun-2005	Sep-2005	Dec-2005	Mar-2006	Jun-2006	Sep-2006	Dec-2006	Mar-2007	Jun-2007	Sep-2007	Dec-2007	Mar-2008	Jun-2008	Sep-2008	Dec-2008	Mar-2009	Jun-2009	Sep-2009	Dec-2009	Mar-2010	Jun-2010	Sep-2010	Dec-2010	Mar-2011	Jun-2011	Sep-2011	Dec-2011	Mar-2012	Jun-2012	Sep-2012	Dec-2012	Mar-2013	Jun-2013	Sep-2013	Dec-2013	Mar-2014	Jun-2014	Sep-2014	Dec-2014	Mar-2015	Jun-2015	Sep-2015	Dec-2015	Mar-2016	Jun-2016	Sep-2016	Dec-2016	Mar-2017	Jun-2017	Sep-2017	Dec-2017	Mar-2018	Jun-2018	Sep-2018	Dec-2018	Mar-2019	Jun-2019	Sep-2019	Dec-2019	Mar-2020	Jun-2020	Sep-2020	Dec-2020	Mar-2021	Jun-2021	Sep-2021	Dec-2021	Mar-2022	Jun-2022	Sep-2022	Dec-2022	Mar-2023	Jun-2023	Sep-2023	Dec-2023	Mar-2024	Jun-2024	Sep-2024	Dec-2024	Mar-2025	Jun-2025	Sep-2025	Dec-2025
Operating Cash Flow
Net Income	1 030	713	506	408	16	123	84	63	342	282	267	251	47	(72)	(122)	(206)	(133)	(53)	35	144	210	215	174	174	181	252	254	202	194	83	64	59	78	112	105	121	144	180	201	237	246	219	266	341	319	342	395	373	415	412	415	431	426	446	549	523	532	550	423	421	429	395	382	389	464	508	538	559	510	547	458	526	531	500	480	461	329	315	408	327	433	430	426	423	494
Depreciation & Amortization	266	268	266	261	259	239	221	206	188	175	171	164	144	138	127	116	117	117	113	114	116	115	115	113	112	113	114	115	115	114	116	116	126	117	116	118	121	137	142	146	139	144	149	155	159	161	163	165	167	167	166	164	162	163	165	168	170	170	168	168	171	176	181	185	186	187	187	188	190	191	192	193	195	196	196	197	198	200	203	209	219	228	236	241	246
Change in Deffered Taxes	202	133	109	62	(26)	(40)	(11)	(27)	50	44	13	23	25	25	18	12	0	3	26	26	60	59	47	46	21	18	11	7	7	0	0	0	(0)	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Other Non-Cash Items	(161)	25	73	106	447	293	289	256	(136)	(116)	(168)	(165)	48	141	263	374	331	275	169	58	(41)	(48)	(10)	(4)	(6)	(4)	(11)	38	23	16	15	(32)	(20)	(36)	(23)	(9)	(35)	(69)	(85)	(97)	(47)	(14)	(32)	(37)	(32)	(36)	(47)	(30)	(39)	(23)	(4)	1	(4)	(21)	(117)	(122)	(118)	(126)	(24)	(27)	(27)	(11)	(13)	(14)	(12)	(16)	(8)	(1)	1	1	6	0	(6)	(15)	(13)	9	47	94	117	100	39	5	(13)	6	(15)
Cash Taxes Paid	(11)	0	35	35	23	23	32	34	34	35	23	20	22	22	8	9	8	7	5	4	4	4	17	18	18	18	19	29	29	29	23	20	30	23	11	9	7	5	12	16	18	19	31	38	38	37	49	59	58	58	76	89	89	89	76	76	76	76	83	87	87	87	85	85	84	84	86	89	89	89	122	132	133	134	98	90	90	90	114	125	125	125	101	96	95
Cash Interest Paid	24	19	17	14	12	10	7	4	2	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2	0	0	0	3	4	5	6	5	6	6	6	5	5	4	3	3	3	4	4	5	6	7	6	6	4
Change in Working Capital	1 498	(1 154)	(1 310)	(1 286)	(119)	59	86	(4)	19	(36)	(19)	(34)	59	40	164	174	102	121	(17)	34	13	27	17	4	(8)	12	(6)	(105)	(93)	(76)	(87)	(45)	(29)	(79)	(60)	(47)	(26)	(41)	29	63	34	18	(35)	(58)	(62)	7	56	73	25	26	(105)	(39)	(54)	(193)	(137)	(179)	(134)	(110)	(120)	(211)	(242)	(159)	(214)	(149)	(298)	(399)	(296)	(546)	(100)	(315)	(368)	294	(139)	94	165	(336)	(120)	(168)	(245)	(105)	(31)	(105)	(26)	(123)	(293)
Cash from Operating Activities	2 835 N/A	(15) N/A	(356) -2 214%	(449) -26%	576 N/A	673 +17%	670 0%	494 -26%	463 -6%	349 -25%	263 -24%	239 -9%	323 +35%	271 -16%	450 +66%	471 +5%	418 -11%	464 +11%	325 -30%	377 +16%	358 -5%	368 +3%	342 -7%	333 -3%	301 -10%	392 +30%	362 -8%	255 -29%	246 -4%	140 -43%	110 -22%	100 -9%	155 +55%	115 -26%	138 +20%	182 +32%	203 +11%	207 +2%	287 +39%	348 +21%	371 +7%	368 -1%	348 -5%	402 +15%	384 -4%	474 +23%	568 +20%	581 +2%	568 -2%	581 +2%	472 -19%	556 +18%	530 -5%	395 -26%	459 +16%	390 -15%	450 +15%	483 +7%	447 -7%	351 -21%	331 -6%	401 +21%	335 -16%	411 +23%	339 -18%	280 -18%	421 +51%	200 -53%	600 +201%	425 -29%	289 -32%	1 014 +251%	581 -43%	774 +33%	828 +7%	332 -60%	455 +37%	442 -3%	482 +9%	530 +10%	660 +24%	558 -15%	622 +11%	547 -12%	432 -21%
Investing Cash Flow
Capital Expenditures	(197)	(199)	(136)	(130)	(151)	(137)	(172)	(169)	(149)	(114)	(84)	(89)	(80)	(90)	(107)	(156)	(192)	(194)	(169)	(122)	(115)	(120)	(125)	(130)	(126)	(116)	(109)	(100)	(77)	(94)	(114)	(106)	(109)	(95)	(84)	(95)	(94)	(87)	(101)	(108)	(147)	(146)	(140)	(127)	(106)	(115)	(162)	(177)	(189)	(202)	(141)	(227)	(292)	(394)	(423)	(337)	(298)	(238)	(232)	(305)	(283)	(336)	(318)	(247)	(265)	(175)	(266)	(400)	(389)	(375)	(430)	(279)	(246)	(275)	(209)	(309)	(342)	(313)	(320)	(296)	(308)	(314)	(247)	(269)	(300)
Other Items	69	1 558	1 693	2 390	1 404	1 331	1 378	887	459	377	308	284	360	391	473	425	679	724	668	613	633	199	(26)	(151)	(383)	59	(13)	(53)	(119)	(351)	(448)	(222)	70	(187)	145	25	186	204	54	(3)	(99)	227	202	230	72	(83)	364	404	482	509	163	132	190	236	400	353	197	179	48	66	149	75	25	(12)	12	60	86	95	37	48	35	38	16	21	33	13	2	(2)	(50)	(68)	20	28	123	120	29
Cash from Investing Activities	(128) N/A	1 359 N/A	1 557 +15%	2 260 +45%	1 253 -45%	1 194 -5%	1 206 +1%	719 -40%	311 -57%	263 -15%	224 -15%	195 -13%	280 +44%	301 +8%	366 +22%	269 -26%	487 +81%	530 +9%	499 -6%	491 -2%	518 +5%	78 -85%	(151) N/A	(281) -86%	(509) -81%	(57) +89%	(121) -113%	(153) -26%	(196) -28%	(445) -127%	(562) -26%	(328) +42%	(39) +88%	(282) -621%	61 N/A	(70) N/A	92 N/A	116 +26%	(48) N/A	(111) -133%	(245) -122%	82 N/A	62 -25%	103 +67%	(33) N/A	(198) -493%	203 N/A	227 +12%	293 +29%	307 +5%	22 -93%	(95) N/A	(102) -7%	(158) -56%	(23) +86%	15 N/A	(101) N/A	(59) +42%	(184) -213%	(238) -29%	(133) +44%	(260) -96%	(292) -12%	(260) +11%	(252) +3%	(114) +55%	(180) -57%	(305) -70%	(351) -15%	(327) +7%	(395) -21%	(242) +39%	(230) +5%	(254) -11%	(176) +31%	(296) -68%	(339) -15%	(314) +7%	(369) -18%	(364) +1%	(288) +21%	(287) +0%	(124) +57%	(149) -21%	(271) -82%
Financing Cash Flow
Net Issuance of Common Stock	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	(781)	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Net Issuance of Debt	(2 202)	(969)	(830)	(857)	(926)	(980)	(880)	(930)	(450)	(250)	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	(4)	(8)	9	87	87	67	25	(27)	160	158	282	238	66	123	(303)	(258)	(284)	(280)	92	80	119	77	13	(28)	(117)	(118)	(108)	(88)
Cash Paid for Dividends	(500)	0	0	(979)	(979)	0	0	(278)	(278)	0	0	(362)	(362)	0	0	0	(139)	0	0	0	0	0	0	(167)	(167)	0	0	(167)	(167)	0	0	(189)	(189)	0	0	(72)	(72)	(72)	(72)	(100)	(100)	(100)	(100)	(200)	(200)	(200)	0	(224)	(224)	0	0	(300)	(300)	0	0	0	(300)	0	0	(360)	(360)	0	0	(300)	(300)	0	0	0	(270)	0	0	(570)	(300)	0	0	(300)	(300)	0	0	(240)	(240)	0	0	(260)	(260)
Other	(8)	6	2	(28)	(10)	(26)	(33)	(13)	(13)	(14)	(4)	(20)	(19)	(16)	(20)	(6)	(8)	(6)	(2)	(0)	1	1	(2)	(2)	(1)	(4)	1	5	5	8	8	3	7	2	(1)	4	5	4	5	1	4	32	33	9	6	(32)	(27)	(1)	(3)	44	22	25	27	(11)	(20)	(23)	(30)	(27)	(4)	(7)	(5)	103	140	150	146	49	7	(3)	4	(3)	19	16	10	9	(3)	13	21	25	16	(1)	1	(8)	(11)	(20)	(15)
Cash from Financing Activities	(2 711) N/A	(1 463) +46%	(1 327) +9%	(1 863) -40%	(1 915) -3%	(1 984) -4%	(1 891) +5%	(1 222) +35%	(741) +39%	(542) +27%	(283) +48%	(382) -35%	(381) +0%	(377) +1%	(382) -1%	(6) +98%	(147) -2 200%	(145) +1%	(141) +3%	(139) +1%	1 N/A	1 -9%	(2) N/A	(169) -6 946%	(168) +1%	(171) -2%	(166) +3%	(162) +3%	(162) +0%	(159) +2%	(159) 0%	(186) -17%	(182) +2%	(187) -3%	(190) -2%	(69) +64%	(849) -1 133%	(850) 0%	(849) +0%	(880) -4%	(96) +89%	(68) +29%	(67) +2%	(191) -186%	(194) -1%	(232) -20%	(227) +2%	(225) +1%	(227) -1%	(180) +21%	(202) -12%	(275) -36%	(273) +1%	(311) -14%	(320) -3%	(323) -1%	(330) -2%	(331) 0%	(312) +6%	(357) -15%	(278) +22%	(170) +39%	(153) +10%	(125) +19%	(181) -45%	(91) +49%	(135) -47%	279 N/A	(28) N/A	(207) -626%	(127) +38%	(857) -574%	(548) +36%	(575) -5%	(583) -1%	(195) +67%	(199) -2%	(156) +22%	(208) -33%	(227) -9%	(267) -18%	(365) -37%	(370) -1%	(389) -5%	(363) +7%
Change in Cash
Effect of Foreign Exchange Rates	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	(0)	0	(0)	(1)	(1)	(1)	0	1	1	1	(0)	(0)	0	0	0	1	0	(1)	0	1	0	1	2	(1)	0	(1)	(4)	(3)	(4)	(3)	(1)	(1)	1	1	(0)	(0)	(0)	(0)	(0)	(1)	(1)	(1)	(0)	0	0	0	0	(0)	1	1	1	0	(0)	(1)	(0)	(0)	(0)	1	1	1	1	(2)	(1)	0
Net Change in Cash	(4) N/A	(119) -3 211%	(127) -7%	(52) +59%	(86) -65%	(117) -36%	(15) +87%	(9) +40%	32 N/A	70 +117%	205 +192%	52 -75%	222 +325%	195 -12%	434 +123%	733 +69%	757 +3%	848 +12%	683 -19%	729 +7%	877 +20%	447 -49%	189 -58%	(117) N/A	(377) -222%	163 N/A	74 -55%	(59) N/A	(111) -86%	(464) -320%	(610) -32%	(415) +32%	(67) +84%	(354) -428%	9 N/A	44 +397%	(553) N/A	(526) +5%	(610) -16%	(642) -5%	31 N/A	381 +1 119%	344 -10%	316 -8%	156 -51%	45 -71%	543 +1 116%	579 +7%	630 +9%	704 +12%	289 -59%	186 -36%	155 -17%	(73) N/A	117 N/A	83 -30%	19 -77%	93 +401%	(49) N/A	(244) -402%	(81) +67%	(31) +62%	(112) -265%	27 N/A	(93) N/A	75 N/A	107 +44%	173 +62%	220 +27%	(108) N/A	(233) -116%	(85) +64%	(197) -133%	(55) +72%	68 N/A	(159) N/A	(84) +47%	(28) +67%	(94) -234%	(60) +36%	107 N/A	(93) N/A	126 N/A	8 -94%	(202) N/A
Free Cash Flow
Free Cash Flow	2 638 N/A	(215) N/A	(492) -130%	(579) -18%	425 N/A	536 +26%	498 -7%	325 -35%	314 -3%	235 -25%	179 -24%	150 -16%	243 +62%	181 -25%	343 +89%	315 -8%	225 -28%	270 +20%	157 -42%	255 +63%	243 -5%	248 +2%	218 -12%	203 -7%	175 -14%	276 +58%	254 -8%	155 -39%	169 +9%	46 -73%	(5) N/A	(6) -38%	45 N/A	20 -55%	54 +166%	88 +62%	110 +25%	120 +9%	186 +56%	240 +29%	224 -7%	222 -1%	208 -6%	275 +32%	278 +1%	359 +29%	406 +13%	404 -1%	378 -6%	379 +0%	331 -13%	330 0%	239 -28%	0 -100%	37 +18 350%	53 +43%	151 +186%	245 +62%	216 -12%	47 -78%	48 +4%	66 +36%	18 -73%	164 +817%	75 -54%	105 +41%	156 +48%	(200) N/A	211 N/A	50 -76%	(141) N/A	734 N/A	335 -54%	499 +49%	619 +24%	23 -96%	113 +389%	130 +15%	163 +25%	235 +44%	353 +50%	244 -31%	375 +54%	278 -26%	132 -53%

Income Statement Balance Sheet Cash Flow Statement

Taiyen Biotech Co Ltd
TWSE:1737

Cash Flow Statement

Cash Flow Statement
Taiyen Biotech Co Ltd

See Also

Company

Help

Tools

Stocks

Taiyen Biotech Co Ltd TWSE:1737

Cash Flow Statement

Cash Flow Statement Taiyen Biotech Co Ltd

See Also

Company

Help

Tools

Stocks

Taiyen Biotech Co Ltd
TWSE:1737

Cash Flow Statement
Taiyen Biotech Co Ltd